126 related articles for article (PubMed ID: 19725224)
21. CD33+ B-cell precursor acute lymphoblastic leukemia in children: a distinct subgroup of B-cell precursor acute lymphoblastic leukemia.
Hara J; Hosoi G; Okamura T; Osugi Y; Ishihara S; Yumura-Yagi K; Kawa-Ha K; Tawa A
Int J Hematol; 1995 Feb; 61(2):77-84. PubMed ID: 7734715
[TBL] [Abstract][Full Text] [Related]
22. Analysis of myeloid characteristics in acute lymphoblastic leukemia.
Tsuchiya H; el-Sonbaty SS; Watanabe M; Suzushima H; Asou N; Murakami T; Takeda T; Shimosaka A; Takatsuki K; Matsuda I
Leuk Res; 1993 Sep; 17(9):809-13. PubMed ID: 7690437
[TBL] [Abstract][Full Text] [Related]
23. Myeloid antigen expression in adult acute lymphoblastic leukemia: clinicohematological correlations and prognostic relevance.
Ferrara F; De Rosa C; Fasanaro A; Mele G; Finizio O; Schiavone EM; Spada OA; Rametta V; Del Vecchio L
Hematol Pathol; 1990; 4(2):93-8. PubMed ID: 2373674
[TBL] [Abstract][Full Text] [Related]
24. Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms.
Nakase K; Kita K; Shiku H; Tanaka I; Nasu K; Dohy H; Kyo T; Tsutani H; Kamada N
Am J Clin Pathol; 1996 Jun; 105(6):761-8. PubMed ID: 8659452
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
26. Frequent but nonrandom expression of myeloid markers on de novo childhood acute lymphoblastic leukemia.
Abdelhaleem M
Exp Mol Pathol; 2007 Aug; 83(1):138-41. PubMed ID: 17434163
[TBL] [Abstract][Full Text] [Related]
27. The immunologic detection of minimal residual disease in acute leukemia.
Campana D; Coustan-Smith E; Janossy G
Blood; 1990 Jul; 76(1):163-71. PubMed ID: 1973061
[TBL] [Abstract][Full Text] [Related]
28. Significance of myeloid antigen expression in precursor T lymphoblastic lymphoma.
Cai Y; Sun XF; Yan SL; Zhen ZJ; Xia Y; Ling JY
Chin J Cancer; 2010 Mar; 29(3):312-6. PubMed ID: 20193116
[TBL] [Abstract][Full Text] [Related]
29. Myeloid markers in adult acute lymphocytic leukemia. Correlations with patient and disease characteristics and with prognosis.
Preti HA; Huh YO; O'Brien SM; Andreeff M; Pierce ST; Keating M; Kantarjian HM
Cancer; 1995 Nov; 76(9):1564-70. PubMed ID: 8635059
[TBL] [Abstract][Full Text] [Related]
30. Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia.
Drexler HG; Thiel E; Ludwig WD
Leukemia; 1991 Aug; 5(8):637-45. PubMed ID: 1886419
[TBL] [Abstract][Full Text] [Related]
31. Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigens.
Kalina T; Vaskova M; Mejstrikova E; Madzo J; Trka J; Stary J; Hrusak O
BMC Cancer; 2005 Apr; 5():38. PubMed ID: 15826304
[TBL] [Abstract][Full Text] [Related]
32. Expression of BCL-2 proto-oncogene in adult acute lymphoblastic leukemia.
Campos L; Sabido O; Sebban C; Charrin C; Bertheas MF; Fière D; Guyotat D
Leukemia; 1996 Mar; 10(3):434-8. PubMed ID: 8642858
[TBL] [Abstract][Full Text] [Related]
33. CD4 predicts nonlymphocytic lineage in acute leukemia. Insights from analysis of 125 cases using two-color flow cytometry.
Larson RS; McCurley TL
Am J Clin Pathol; 1995 Aug; 104(2):204-11. PubMed ID: 7543728
[TBL] [Abstract][Full Text] [Related]
34. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
35. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
[TBL] [Abstract][Full Text] [Related]
36. Immunoglobulin and T-cell receptor gene rearrangements in acute lymphoblastic leukemia--a higher incidence of double rearrangements in patients with myeloid antigen expression.
Tien HF; Wang CH; Su IJ; Wu HS; Chien SH; Chen YC; Lin DT; Lin KH; Shen MC
Leuk Res; 1991; 15(2-3):91-8. PubMed ID: 1850056
[TBL] [Abstract][Full Text] [Related]
37. Correlation of CD33 with poorer prognosis in childhood ALL implicates a potential of anti-CD33 frontline therapy.
Mejstríková E; Kalina T; Trka J; Starý J; Hrusák O
Leukemia; 2005 Jun; 19(6):1092-4. PubMed ID: 15830012
[No Abstract] [Full Text] [Related]
38. Clinical features and treatment outcome of children with myeloid antigen coexpression in B-lineage acute lymphoblastic leukemia: a study of 151 Malaysian children.
Ng SM; Ariffin WA; Lin HP; Chan LL; Chin YM
J Trop Pediatr; 2000 Apr; 46(2):73-8. PubMed ID: 10822932
[TBL] [Abstract][Full Text] [Related]
39. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
Zhao F; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.
Molica S; Mannella A; Dattilo A; Levato D; Iuliano F; Peta A; Consarino C; Magro S
Haematologica; 1996; 81(4):302-9. PubMed ID: 8870373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
